Vern Davenport

Board Member at Clinical Ink

Vern Davenport brings more than 30 years of executive experience in building and transforming healthcare technology and service companies. Before joining NovaQuest, Mr. Davenport was CEO and board member at Medfusion, a leader in healthcare consumerism technology where he was instrumental in the carve-out of the company from Intuit and the return of its core portal solution to a market leadership position. Operationally, he created a culture that earned a Best Places to Work award from Triangle Business Journal. In less than twelve months, the company developed and released two new products in patient payments and consumer patient record integration leveraging both cloud and mobile technologies. Prior to Medfusion, Mr. Davenport was chairman and CEO of Medquist and leader in transcription services before and after the privatization of the company. As chairman and CEO, Mr. Davenport facilitated a transformation of the business through the acquisition of a speech technology company, rebranding the company M*Modal and leading the take private process that resulted in the sale of the business to One Equity Partners. Mr. Davenport’s previous experience also includes his time as president of Allscripts, CEO of Misys Healthcare, GM and EVP of Kodak Health Group (now Carestream Health) and his time in executive leadership roles at Siemens Shared Medical Systems. Mr. Davenport began his career at IBM, where he spent eleven years in sales, sales leadership and executive management positions. Mr. Davenport received a master of business administration from East Carolina University as well as a bachelor of science in business administration. Mr. Davenport currently serves on the East Carolina Board of Trustees as well as the WakeMed Health and Hospitals board.


  • Board Member

    Current role


By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.